Furthermore, although we have established a positive regulatory relationship between IRF5 and HLA‐E, further investigations are required to elucidate how IRF5 modulates HLA‐E expression at the transcriptional level and to determine the specific implications of this process in lung cancer development. Here, IRF5 is linked to lung carcinoma.